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ABSTRACT
Objective: To assess the quality of reported consent
processes of cluster-randomised trials conducted in
residential facilities for older people and to explore
whether the focus on improving the general conduct
and reporting of cluster-randomised trials influenced
the quality of conduct and reporting of ethical
processes in these trials.
Design: Systematic review of cluster-randomised trials
reports, published up to the end of 2010.
Data sources: National Library of Medicine (Medline)
via PubMed, hand-searches of BMJ, Journal of the
American Medical Association, BMC Health Services
Research, Age and Ageing and Journal of the American
Geriatrics Society, reference search in Web of
Knowledge and consultation with experts.
Eligibility for selecting studies: Published cluster-
randomised trials where the unit of randomisation is a
part or the whole of a residential facility for older people,
without language or year of publication restrictions.
Results:We included 73 trials. Authors reported ethical
approval in 59, obtaining individual consent in 51, and
using proxies for this consent in 37, but the process to
assess residents’ capacity to consent was clearly
reported in only eight. We rated only six trials high for the
quality of consent processes. We considered that
individual informed consent could have been waived
legitimately in 14 of 22 trials not reporting obtaining
consent. The proportions reporting ethical approval and
quality of consent processes were higher in recent trials.
Conclusions: Recently published international
recommendations regarding ethical conduct in cluster-
randomised trials are much needed. In relation to
consent processes when cognitively impaired individuals
are included in these trials, we provide a six-point
checklist and recommend the minimum information to
be reported. Those who lack capacity in trials with
complex designs should be afforded the same care in
relation to consent as competent adults in trials with
simpler designs.
INTRODUCTION
The increasing number of frail older people
in our population is a major challenge for
healthcare in the 21st century. Good care for
older people should be based on high-
quality, ethically sound, relevant research
involving this patient population.1 This must
include studies in nursing and residential
homes, where many of the growing numbers
of frail older people live. Research in these
settings poses ethical challenges, not least
because many residents of nursing and
residential homes are cognitively impaired,2
and therefore may have difﬁculty in
ARTICLE SUMMARY
Article focus
▪ The overall quality of consent processes in
cluster-randomised trials (CRTs) conducted in
residential facilities for older people.
▪ The standard of reporting of consent processes
and research ethics approval in publications
describing CRTs in this context.
▪ The potential association between the quality of
this reporting and other quality markers such as
accounting for clustering.
Key messages
▪ The majority of investigators of CRTs in nursing
and residential homes understand when it is
necessary to obtain individual consent for resi-
dents’ participation.
▪ The ethical principles underlying the need to
assess capacity and the use of proxies appear to
be poorly understood in these trials.
▪ The quality of reporting ethical approval and
consent processes is also poor in these trials.
Strengths and limitations of this study
▪ The relatively small number of included trials
precludes extensive formal statistical analyses of
associations between the quality of consent pro-
cesses and possible determinants.
▪ Published reports may not fully reflect the ethical
procedures because of space limitations.
▪ The criteria we used to assess whether individual
consent for participation was needed in a trial
were compiled to help those designing trials and
not easy to use for assessment of trial reports.
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understanding information usually provided in consent
processes or may lack capacity to consent to participate.
International ethical standards for research include
the requirement for valid consent from participants who
have capacity,3 the obligation to take all practical mea-
sures to maximise understanding and facilitate capaci-
tous consent, and the adherence to appropriate
guidance when capacity is lacking. Since capacity is deci-
sion speciﬁc, researchers must assess capacity for each
potential participant during the recruitment process;
reliance on the opinion of others, standardised tests or
previous assessments of capacity for other decisions is
not adequate.4–7 If an individual lacks capacity, research-
ers should follow the relevant regulatory framework
depending on the nature of the study and the legal juris-
diction in which it takes place. However, guidance on
the conduct of research involving people who lack cap-
acity is often not clearly understood, even by research
ethics committees8 or easily put into practice.9
When cluster-randomised trials are conducted in resi-
dential homes, there are additional ethical challenges, as
well as statistical challenges.10–12 In these trials, clusters are
randomised rather than individuals themselves. When the
interventions being evaluated are aimed primarily at
homes, for example, a change in the type of light ﬁttings,13
an individual’s refusal to participate is meaningless,
though there may still be a need to obtain individual
consent for assessment of outcome measures and for data
collection.14 An international research group recently pro-
duced draft recommendations to clarify appropriate
ethical conduct in cluster randomised trials, including
recommendations about when investigators need to
obtain individual consent to participate in these trials and
when they do not. In line with international ethical guide-
lines, the group recommend that consent be obtained
from research participants unless a waiver of consent has
been approved by the relevant research ethics commit-
tee.15 However, a recent review of 300 cluster randomised
trials by this research group showed that investigators were
less likely to report obtaining ethical approval and to
report obtaining participant consent than in individually
randomised trials.16 The International Committee of
Medical Journal Editors requires authors to indicate
whether the research reported complied with the stan-
dards set by the relevant research ethics committee and
were in accordance with the Helsinki Declaration.17
Where there is doubt about compliance with the
Declaration, the requirements state that ‘the authors must
explain the rationale for their approach and demonstrate
that the institutional review body explicitly approved the
doubtful aspects of the study’. As cluster randomised trials
raise concerns about appropriate consent processes, there
is an obligation on researchers to report the approach
taken and their reasons for it. Given the risk of lack of
decision-making capacity in this research population, this
obligation could be expected to include reporting pro-
cesses for assessing capacity and compliance with the rele-
vant regulation when participants lack capacity.
As a result of our own efforts to conduct consent pro-
cesses in a large cluster-randomised trial in nursing and
residential homes in the UK,18 we wanted to explore, as
part of a systematic review of the quality of such trials
(paper submitted), how other researchers had
approached this double challenge of ethical conduct in
cluster-randomised trials in nursing and residential
homes, and provide guidance for future investigators. In
this paper, we make speciﬁc recommendations for
improving the reporting and conduct of consent pro-
cesses in these trials based on weaknesses we identify in
reporting, conducting consent processes, and under-
standing when consent from participants is and is not
necessary. We also explore whether the focus on improv-
ing the general conduct and reporting of cluster-
randomised trials and discussions of ethical issues in
these trials in the early part of the 21st century was asso-
ciated with a change in the quality of conduct and
reporting of ethical processes in these trials. In addition,
we assess whether the reporting of these processes was
of higher quality if the trials appeared to be of higher
quality in other respects.
METHODS
Inclusion and identification
We included cluster-randomised trials conducted in resi-
dential facilities for older people. We used the Medical
Subject Headings deﬁnition of residential care facilities:
long-term care facilities which provide supervision and
assistance in activities of daily living with medical and
nursing services when required, and extended this deﬁn-
ition to include other group-living arrangements where
some care is provided, for example, retirement villages.
Trials were included if the unit of randomisation was the
facility or a part of it, for example, a ward, wing or ﬂoor,
and the majority of the trial participants were 60 years
old or over. We included all such trials published up to
the end of 2010, without language restrictions. We
searched PubMed in January 2011 for reports of relevant
trials (full search strategy in table A in web appendix A).
In addition, we hand-searched the electronic archives of
ﬁve journals (British Medical Journal, Journal of the
American Medical Association, BMC Health Services Research,
Age and Ageing and the Journal of the American Geriatrics
Society) back to 2001, reviewed the references of each eli-
gible report identiﬁed using Web of Knowledge, and
contacted experts to identify any further trials.
Secondary reports of the same trial were excluded.
Data extraction
One researcher extracted data from all reports; a
second, independent extraction was carried out by other
members of the research team. We used written guid-
ance on extraction, agreed in advance, resolving discrep-
ancies by discussion. We extracted data from all trial
reports on whether approval by an ethics committee and
individual consent/assent were reported. If consent/
2 DiazOrdaz K, Slowther A-M, Potter R, et al. BMJ Open 2013;3:e003057. doi:10.1136/bmjopen-2013-003057
A systematic review of consent processes of CRTs in residential homes
 group.bmj.com on July 11, 2013 - Published by bmjopen.bmj.comDownloaded from 
assent was reported, we extracted all quotes relating to
consent processes. We emailed twice a 10% sample of
authors for further information. For trials in which indi-
vidual consent/assent was not reported, we extracted
data on type of intervention and method of data collec-
tion in order to judge whether it would have been legit-
imate not to obtain consent for individual participation.
Data on year of publication and markers of methodo-
logical quality were extracted from the trial reports, as
part of a review of the quality of these trials, based on
the same sample (paper submitted). Following a previ-
ous review,16 we used accounting for clustering in the
sample size calculations and analysis of the trials as two
methodological quality markers, and publication in a
journal putting a stronger emphasis on following the
CONSORT statement as a marker of journal focus on
the quality of reporting in general, although this state-
ment does not explicitly recommend reporting ethical
approval and consent (see web appendix A for details).
The review protocol is available from authors.
Analysis
To assess reporting, we present proportions reporting
ethical approval and seeking individual consent for par-
ticipation and, for trials for which authors reported
obtaining such consent, proportions assessing capacity,
using proxies for consent (including type of proxy),
excluding cognitively impaired individuals and obtaining
consent only in the intervention arm.
To assess the conduct of consent processes, two
researchers independently scored the quality of the cap-
acity assessment, use of proxies and processes for obtain-
ing assent using the criteria shown in table 1, resolving
discrepancies by discussion. The scores from each of
these were summed to provide a total score for the
quality of consent processes: high (score=3 or higher),
medium (score=2) or low (score=1). Some reports did
not provide enough information to provide a score.
Two researchers independently judged whether such
consent was necessary in trials for which the authors
had not reported obtaining individual consent, using
guidance produced by an international research group
that has produced ethical guidelines for cluster-
randomised trials. This group deﬁned research
participants as anyone in at least one of the following
categories: (1) a recipient of an experimental (or
control) intervention; (2) someone who is the direct
target of an experimental (or control) manipulation of
his/her environment; (3) someone from whom a
researcher collects data about that individual (4) or
someone about whom an investigator obtains identiﬁ-
able private information for the purpose of collecting
data.15 We ﬁrst judged home residents as research parti-
cipants if they fell into either category (1) or (2). When
they did not, we additionally examined data collection
procedures, assessing residents as research participants if
they fell into category (3) or (4). When we found it difﬁ-
cult to judge whether collection from routine data
involved identiﬁable private information, and the inter-
vention procedures posed no more than minimal risk,
we assumed that a waiver of consent would have been
acceptable.
To explore any association between the focus on
improving reporting in general and discussion of ethical
issues in cluster trials in the early part of the 21st
century, and the conduct and reporting of ethical pro-
cesses in such trials, we present proportions reporting
ethical approval, individual consent and the quality of
the consent processes for studies reported in or before
or after the publication of the extended CONSORT
statement for cluster-randomised trials in 2004. Various
publications discussing the ethical conduct of trials were
published just before or around the same time.11 12 14 19
Table 1 Criteria to assess quality of consent/agreement processes and associated scores
Issue Criterion used to assess quality Score
Assessing
capacity
Evidence that the individual had been given information relevant to the trial and their
understanding was assessed directly by the trial team
2
Researchers applied an instrument to measure the level of cognitive impairment (eg, mini-mental
state examination) to each individual and based their assessment of capacity to consent on this
1
A carer (eg, nursing home staff and general practitioner) was shown the study information sheet
and asked to give an opinion whether the individual would be able to understand the information
in order to give informed consent
1
Researchers based their consent process on the level of cognitive impairment as perceived by
the carers without specific reference to the information needed to understand the trial
0
Use of proxies For participants who were deemed to lack capacity, consent/agreement was obtained from next
of kin/legal representative/carer
1
Consent/agreement was not obtained from next of kin/legal representative/carer 0
Assent procedure
(if consent was
obtained via
proxy)
Verbal assent was obtained from the participants when receiving the intervention treatment or at
the time of data collection ORIf neither treatment nor data collection involved the participant
directly (eg, data collected from medical records), assent was not required
1
No assent was obtained 0
DiazOrdaz K, Slowther A-M, Potter R, et al. BMJ Open 2013;3:e003057. doi:10.1136/bmjopen-2013-003057 3
A systematic review of consent processes of CRTs in residential homes
 group.bmj.com on July 11, 2013 - Published by bmjopen.bmj.comDownloaded from 
We also examined trends over time in reporting ethical
approval, reporting individual consent and quality of the
consent processes, using logistic regression or ordinal
logistic regression as appropriate, testing for assumptions
of the models as appropriate and using a 5% signiﬁ-
cance level in all analyses. Analyses were undertaken in
Stata, V.11.20
To see whether ethical reporting and conduct are
better addressed by those whose trial reports were of
higher quality in other respects or published in journals
that put a greater emphasis on the quality of reporting,
we ﬁtted further logistic and ordinal regression models
as appropriate, with accounting for clustering in sample
size calculations, accounting for clustering in the analysis
and the strength of the journal’s endorsement of the
extended CONSORT statement (no endorsement and
weak endorsement vs moderate and strong endorse-
ment) as predictors.
RESULTS
We identiﬁed 308 published reports via our electronic
search, rejecting 248 on the basis of titles or abstracts.
Additionally, 27 reports were found by hand-searching
and reference-searching and three from consulting
experts, making a total of 90 full-text papers to be exam-
ined (ﬁgure 1 in web appendix B). From these, 73
primary reports met our eligibility criteria (see table C
in web appendix C for a full-reference list). Basic charac-
teristics are reported in table 2.
The strength of the CONSORT endorsement of the
journals is reported in table B in web appendix
A. Authors reported obtaining approval from a research
ethics committee in 59 (81%) trials, obtaining individual
consent to participate in 51 (70%) trials and obtaining
both in 45 (62%) trials.
Among the 51 trials in which authors reported obtain-
ing individual consent, the process used to assess cap-
acity was described in detail for only 8 trials: in 4 trials,
researchers asked the general practitioner or main staff
carer for an assessment of capacity, and in 4 other trials,
they interviewed each eligible resident. Nevertheless,
proxies, usually next of kin, were used for consent in 37
trials (table 3). Six of these trials, evaluating speciﬁc
dementia interventions, described their processes in suf-
ﬁcient detail for us to ascertain that they deﬁnitely did
not assess capacity in any residents. In a further six
trials, those deemed cognitively impaired were excluded
from the trial, and in three other trials, consent was
sought only in the experimental intervention arm. We
rated only six publications as high for the quality of
consent processes; none scored the maximum possible
of six points. Twenty-two trial reports (43%) did not
contain sufﬁcient detail for us to score them. We did not
receive any replies to our emails to a 10% sample of
authors for further information about processes for
assessing capacity and obtaining consent.
Of the 22 trials for which authors did not report
obtaining individual resident consent, we judged that in
14 consent was either not required, or the description
made it difﬁcult to judge if consent was required, but if
it had been, a waiver of consent could been appropriate
(table 3). Examples of interventions used in these trials
were staff training in fall prevention, or inﬂuenza vaccin-
ation administered to residence staff. In 8 of these 14
trials, authors reported obtaining ethical approval. Of
the 8 of the 22 trials that we judged needed consent
from individual participants, 1 included an intervention
aimed directly at residents, 1 included an intervention
that was a manipulation of a resident’s environment;
both papers reported obtaining ethical approval. Five
trials collected data directly from participants, and one
collected identiﬁable data from other sources; of these,
four reported obtaining ethical approval.
As we judged that only eight of the trials in the review
that did not report obtaining individual consent needed
to do so, we did not perform any formal statistical ana-
lyses related to the propensity to obtain consent. There
was a 14% higher odds of reporting ethical approval per
year (95% CI 1.01 to 1.29). Ethical approval was more
likely to be reported for trials in which clustering was
accounted for correctly in the sample size calculation
(OR 6.17 (95% CI 0.76 to 50.73)) and in the analysis
(OR 2.66 (95% CI 0.78 to 9.03)). Among reports pub-
lished post-2004 (44 reports), the odds of reporting
ethical approval was 8.85 (95% CI 1.34 to 58.34) times
higher among those reports published in journals with
moderate-to-strong extended CONSORT endorsement,
when compared with those published in journals with
low CONSORTendorsement.
Among those trials for which authors reported obtain-
ing individual consent, the quality of consent processes
Table 2 Characteristics of included reports
Characteristic
Number of
trials (%)
Publication year
Published between 1992 and 2004 29 (40)
Published between 2005 and 2010 44 (60)
Country
USA 17 (23)
UK 16 (22)
The Netherlands 9 (12)
Canada* 7 (10)
Australia 5 (7)
Sweden 5 (7)
Others 14 (19)
Clustering accounted for in sample size
calculation
20 (27)
Clustering accounted for in analysis 54 (74)
Journal of publication endorses
extended CONSORT statement for
cluster-randomised trials
(moderate-to-strong endorsement)†
33 (75)
*Of which two jointly with the USA.
†Based on the 44 reports published after 2004.
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appeared to improve over time (ordinal logistic OR 1.12
(95% CI 0.98 to 1.28)). Relationships between other
quality markers and the quality of consent processes
were weaker and not statistically signiﬁcant at the 5%
level, with ordinal logistic ORs of 1.65 (95% CI 0.53 to
5.12) for the association with accounting for clustering
in the sample size calculation, 2.49 (95% CI 0.77 to
8.04) for the association with accounting for clustering
in the analysis and 0.84 (95% 0.16 to 4.39) for the asso-
ciation with CONSORTendorsement.
DISCUSSION
The majority of authors of trials in our review appeared
to correctly understand when consent for residents’ par-
ticipation was needed. However, the quality of reporting
the ethical approval and consent processes was generally
poor. Furthermore, 16% of trials reported ethically ques-
tionable practices: 8% seeking proxy consent without an
assessment of residents’ capacity, and 8% excluding
patients with cognitive impairment without this assess-
ment. Authors of 22 trials did not provide enough infor-
mation for us to comment on the ethical quality of their
consent processes. Trials published later are more likely
to report obtaining ethical approval and have higher
quality consent processes. The reporting of ethical
approval but not the quality of the consent process
appears higher in trials in which other methodological
quality markers and journal endorsement of reporting
quality were also high.
Strengths and weaknesses
Our rigorous review processes ensured that we included
the majority of cluster randomised trials in residential
and nursing homes. In spite of the limited potential for
statistical analysis with only 73 trials in total and only 51
reporting obtaining consent, our data suggest some
trends in reporting of ethical approval and processes
and some associations with other quality markers,
though it is difﬁcult to ascertain whether these trends
are sustained, as we have not included papers reported
since 2011.
Our assessment of the quality of consent processes
may not fully reﬂect conduct because space limitations
in journals can preclude detailed descriptions. Owing to
a lack of data, we were unable to assess the extent
to which investigators had modiﬁed information given to
potential participants to allow for cognitive impairment.
Table 3 Prevalence of characteristics of consent processes stratified by whether obtaining of individual consent was
reported
Trials that report obtaining individual consent
Total
N=51
Report obtaining
ethical approval
N=45
Did not report
obtaining ethical
approval N=6
Published
1992–2004
N=22
Published
2005–2010
N=29
Reporting using proxy for consent 37 (72%) 34 (76%) 3 (50%) 13 (59%) 24 (83%)
Type of proxy
Next of kin or other relative 19 (37%) 19 (42%) 0 (0%) 8 (36%) 11 (38%)
Family members or guardians 6 (12%) 4 (9%) 2 (33%) 3 (14%) 3 (10%)
Legal or designated guardian 11 (22%) 10 (22%) 1 (17%) 2 (9%) 9 (31%)
Member of staff or relative 1 (3%) 1 (2%) 0 (0%) 0 (0%) 1 (3%)
Reported process to assess
capacity
8 (16%) 7 (16%) 1 (16%) 2 (9%) 6 (21%)
Quality of consent process:
Insufficient details reported 22 (43%) 18 (40%) 4 (67%) 12 (59%) 10 (31%)
Poor 15 (29%) 15 (34%) 0 (0%) 5 (23%) 10 (34%)
Fair 8 (16%) 7 (16%) 1 (17%) 3 (14%) 5 (17%)
High 6 (12%) 5 (11%) 1 (17%) 2 (9%) 4 (14%)
Trials that did not report obtaining individual consent
Total
N=22 N=14 N=8 N=7 N=15
No consent needed because of
nature of intervention and data
collection*
14 8 (57%) 6 (75%) 5 (72%) 9 (60%)
Consent needed because of data
collection procedures
6 4 (29%) 2 (25%) 1 (14%) 5 (33%)
Consent needed because of type of
intervention
2 2 (14%) 0 (0%) 1 (14%) 1 (7%)
*The intervention was aimed directly at the cluster or cluster staff, and there was no direct data collection from the home residents; there might
have been identifiable private information obtained from other sources, but this was unclear and, if there were, we judged that a waiver could
have been appropriate.
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Since we were unable to obtain further information
from the selected sample of authors, it is not possible to
establish the extent to which our ﬁndings reﬂect deﬁ-
ciencies in study conduct or reporting or both.
Moreover, the nature of the cluster intervention
means that on many occasions a component of the inter-
vention is targeted at the residential home staff or at the
healthcare professionals dedicated to the home. In
these cases, the corresponding staff would be considered
as research participants. As the focus of the present
study was residents’ consent procedures, we did not
extract details on the nature of interventions, except for
those 22 studies that did not report obtaining consent
from the residents or their representatives. Among those
studies, 21 interventions were targeted at the home staff
or healthcare professionals, and informed consent
should therefore have been obtained from them.
However, only one study explicitly reported obtaining
such consent.
While this study supports previous research suggesting
that reporting of ethics processes in cluster-randomised
trials is poor,16 it also provides reassurance that in
general investigators are aware of the need to gain
consent when necessary. Our study raises some con-
cerns, however, about the processes of obtaining a valid
consent in cluster-randomised trials including partici-
pants with cognitive impairment. In this area, the
correct ethical processes may be less well understood. In
addition, investigators conducting cluster-randomised
trials may have greater opportunity to overlook appropri-
ate ethical processes in obtaining individual consent
than investigators conducting individually randomised
trials because the focus in trial design is on initial
recruitment, consent and randomisation of homes
rather than of individuals.
In 2004, a review of publications of trials including
participants with Alzheimer’s disease showed a similar
lack of reporting of research ethics review and consent
processes.21 A review of 300 cluster-randomised trials
found slightly higher proportions of trials reporting
ethics committee reviews and obtaining consent.16 This
probably reﬂects the recent timescale of that review and
the fact that it was not restricted to trials in residential
and nursing homes. That review suggested, as does our
review, greater reporting of ethical approval by authors
of more recent trials and by authors of trials in which
clustering was accounted for in the sample size calcula-
tions. Previous research highlights that assessing capacity
can be difﬁcult; that even experienced assessors often
disagree in their assessment22; that response rates from
next of kin can be disappointing23 24; and that proxy
decisionmakers tend to be less likely to consent to
research than participants themselves.25 As far as we
know, however, no previous work has attempted to
review and score the quality of consent processes within
empirical trials that include substantial numbers of
adults who lack capacity. Similarly, we know of no previ-
ous research exploring the extent to which investigators
in cluster-randomised trials follow appropriate ethical
processes in relation to obtaining individual consent.
We agree with previous researchers that improvements
are needed in the reporting of ethical approval and
consent processes in cluster-randomised trials,16 as well
as in research with vulnerable adults.21 Without consist-
ent accurate reporting, it is difﬁcult to be sure that
appropriate processes have been followed, or to improve
such processes via further research and development. As
full details of consent processes can take up consider-
able space, we recommend that a full description is
given in an on-line supplement and a brief summary in
the main article, at a minimum including whether or
not investigators obtained ethics approval and consent
for individual participation; if they did obtain such
consent, who from; if they did not obtain consent, why
Box 1 Guidelines for individual informed consent pro-
cesses in adults involved in cluster-randomised trials in
nursing or residential homes
1 The need for individual informed consent should be assessed
using the recently drafted Ottawa guidelines recommendations
regarding who a research participant is in these trials. An
ethics committee should approve any decision not to obtain
consent because individuals are not considered as research
participants. Consent should be obtained from all research par-
ticipants unless the appropriate ethics committee agrees to a
waiver. This waiver should be obtained even when the indivi-
duals are not research participants but routinely collected data
pertaining to the individuals are to be used, and these data are
not fully anonymised
2 Where individual consent is required, the potential participant
should be approached in the first instance and provided with
information in an appropriate form to facilitate understanding
and promote capacity3 26
3 If there is concern that the person does not have capacity,
either during the consent process or because of a previously
diagnosed cognitive impairment, capacity should be explicitly
assessed by the researcher and recorded in the study docu-
mentation together with the next step in the consent process
in accordance with the relevant legal framework (seek consent
if person has capacity; identify a legally authorised proxy or
consultee if person lacks capacity)3 26
4 Exclusion of potential participants because of cognitive impair-
ment should be explicitly justified (someone with cognitive
impairment should not be assumed to lack capacity)26
5 Inclusion of participants who lack capacity should be explicitly
justified. (The research cannot be carried out with people who
have capacity and will directly benefit the participant or others
with the same condition)3
6 Tests of cognitive function, such as the Mini Mental State
Examination (MMSE), cannot be used as a proxy for capacity,
but there is some evidence that they can be useful as a screen-
ing tool to identify participants in whom a full assessment of
capacity is required27 28
7 For those who lack capacity, if data collection or the interven-
tion involves participants directly, then their assent should be
obtained at the time of data collection or intervention3
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not; and who assessed capacity if this was necessary.
While the accurate reporting of consent processes is
important for transparency and ethical accountability, a
more fundamental requirement is that the consent
process does in fact comply with accepted ethical princi-
ples and regulatory standards. We have uncovered a
need for greater understanding of how to conduct the
consent process when researchers face the double chal-
lenge of including vulnerable adults in cluster-
randomised trials. Based on our ﬁndings, we present a
guide to best practice for research involving older frail
adults in residential care (box 1). All items are based on
best practice with regard to the information we extracted
from the trials in this review. Item 1 refers to the need
to obtain ethical approval and consent and the judge-
ment about whom to approach for consent. Items 2–6
refer to the information we extracted on the process for
assessing capacity and obtaining consent. The guide
draws on relevant ethical and legal requirements includ-
ing the Declaration of Helsinki, the Mental Capacity Act
(England and Wales), and the Ottawa Statement. That
the research is complex and obtaining valid consent is
difﬁcult is not a justiﬁcation for treating this group of
research participants with less care in relation to consent
than that afforded to participants in a standard individu-
ally randomised trial involving competent adults.
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